Kuroda, H.; Ichinose, J.; Masago, K.; Takahashi, Y.; Nakada, T.; Nakao, M.; Okumura, S.; Hashimoto, K.; Matsuura, Y.; Sakakura, N.;
et al. Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer. Medicina 2021, 57, 1365.
https://doi.org/10.3390/medicina57121365
AMA Style
Kuroda H, Ichinose J, Masago K, Takahashi Y, Nakada T, Nakao M, Okumura S, Hashimoto K, Matsuura Y, Sakakura N,
et al. Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer. Medicina. 2021; 57(12):1365.
https://doi.org/10.3390/medicina57121365
Chicago/Turabian Style
Kuroda, Hiroaki, Junji Ichinose, Katsuhiro Masago, Yusuke Takahashi, Takeo Nakada, Masayuki Nakao, Sakae Okumura, Kohei Hashimoto, Yosuke Matsuura, Noriaki Sakakura,
and et al. 2021. "Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer" Medicina 57, no. 12: 1365.
https://doi.org/10.3390/medicina57121365
APA Style
Kuroda, H., Ichinose, J., Masago, K., Takahashi, Y., Nakada, T., Nakao, M., Okumura, S., Hashimoto, K., Matsuura, Y., Sakakura, N., Matsushita, H., & Mun, M.
(2021). Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer. Medicina, 57(12), 1365.
https://doi.org/10.3390/medicina57121365